FI
SLNO

Fosun International’s Soleno Therapeutics SLNO Stock Holding History

Fosun International’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12,599
Closed -$514K – 284
2019
Q2 		$514K Hold
12,599
– – 0.03% 217
2019
Q1 		$397K Buy
12,599
+571
+5% +$15.2K 0.03% 234
2018
Q4 		$294K Buy
+12,028
New +$351K 0.02% 257

Other funds holding SLNO

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fosun International's SLNO Position: Q3 2019 in Review

Fosun International sold out of Soleno Therapeutics (SLNO) in Q3 2019, closing a stake of 12,599 shares — an estimated $514K sold.

Fosun International first reported a position in SLNO in Q4 2018 and held it in 3 quarters. The position peaked at $514K in Q2 2019. 18 funds tracked by Wall St. Rank hold SLNO as of Q3 2019.

  • Fosun International reported no remaining Soleno Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 12,599 Soleno Therapeutics shares in Q3 2019, an estimated $514K.
  • Fosun International first reported a position in Soleno Therapeutics in Q4 2018 and held it in 3 quarters.
  • Fosun International's Soleno Therapeutics position peaked at $514K in Q2 2019.
  • 18 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.